Chawla Y - Search Results

1

Assessment of dried blood samples as an alternative less invasive method for detection of Hepatitis E virus marker in an outbreak setting.

Singh MP, Majumdar M, Budhathoki B, Goyal K, Chawla Y, Ratho RK. Singh MP, et al. Among authors: chawla y. J Med Virol. 2014 Apr;86(4):713-9. doi: 10.1002/jmv.23874. Epub 2013 Dec 30. J Med Virol. 2014. PMID: 24375126

2

Detailed investigation of ongoing subclinical hepatitis E virus infections; occurring in outbreak settings of North India.

Majumdar M, Singh MP, Goyal K, Chawla Y, Ratho RK. Majumdar M, et al. Among authors: chawla y. Liver Int. 2015 Mar;35(3):826-33. doi: 10.1111/liv.12568. Epub 2014 May 20. Liver Int. 2015. PMID: 24750588

3

Role of TLR gene expression and cytokine profiling in the immunopathogenesis of viral hepatitis E.

Majumdar M, Ratho RK, Chawla Y, Singh MP. Majumdar M, et al. Among authors: chawla y. J Clin Virol. 2015 Dec;73:8-13. doi: 10.1016/j.jcv.2015.09.011. Epub 2015 Oct 9. J Clin Virol. 2015. PMID: 26512422

4

Chronic Hepatitis E With Genotype 1-Masquerading as Allograft Rejection After LiverTransplantation.

Rathi S, Duseja A, Thakur V, Ratho RK, Singh MP, Taneja S, Das A, Aggarwal R, Dhiman RK, Chawla YK. Rathi S, et al. J Clin Exp Hepatol. 2021 May-Jun;11(3):400-403. doi: 10.1016/j.jceh.2020.07.006. Epub 2020 Jul 18. J Clin Exp Hepatol. 2021. PMID: 33994721 Free PMC article.

5

High levels of circulating HMGB1 as a biomarker of acute liver failure in patients with viral hepatitis E.

Majumdar M, Ratho R, Chawla Y, Singh MP. Majumdar M, et al. Among authors: chawla y. Liver Int. 2013 Oct;33(9):1341-8. doi: 10.1111/liv.12197. Epub 2013 May 19. Liver Int. 2013. PMID: 23682703

6

NLRP3 Inflammasome Activation is a Prognostic Marker of Recovery in HEV-Infected Patients.

Thakur V, Ratho RK, Singh MP, Chawla Y, Taneja S. Thakur V, et al. Among authors: chawla y. Curr Microbiol. 2022 Jan 4;79(2):44. doi: 10.1007/s00284-021-02736-x. Curr Microbiol. 2022. PMID: 34982235

7

Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients.

Singla B, Chakraborti A, Sharma BK, Kapil S, Chawla YK, Arora SK, Das A, Dhiman RK, Duseja A. Singla B, et al. J Med Virol. 2013 Jul;85(7):1155-62. doi: 10.1002/jmv.23608. J Med Virol. 2013. PMID: 23918533

8

Levels of hepatitis B virus replicative intermediate in serum samples of chronic hepatitis B patients.

Singla B, Chakraborti A, Sharma BK, Kapil S, Chawla YK, Arora SK, Das A, Dhiman RK, Duseja A. Singla B, et al. Mol Biol Rep. 2014 Jul;41(7):4689-96. doi: 10.1007/s11033-014-3339-7. Epub 2014 Apr 6. Mol Biol Rep. 2014. PMID: 24706057

9

Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis.

Sharma A, Chakraborti A, Das A, Dhiman RK, Chawla Y. Sharma A, et al. Among authors: chawla y. Immunology. 2009 Sep;128(1 Suppl):e514-22. doi: 10.1111/j.1365-2567.2008.03021.x. Epub 2008 Nov 24. Immunology. 2009. PMID: 19740312 Free PMC article.

10

Changing epidemiology of hepatitis A infection.

Gupta A, Chawla Y. Gupta A, et al. Among authors: chawla y. Indian J Med Res. 2008 Jul;128(1):7-9. Indian J Med Res. 2008. PMID: 18820351 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

485 results

Search Page

Filters